Table 1.
Female/male | 100/0 | |
Median age | 50 (30-78) | |
Median time from initial diagnosis to enrollment | 1007(2-6801) | |
Median overall survival time (Days) | 481(1-4465) | |
Median initial TRACP-5b activity (U/L) | 3.894 (1.21-24.245) | |
Median CEA (ng/ml) | 3.5 (1-8165) | |
Median CA-153 (U/ml) | 42.15 (6.59-3040) | |
ER | positive | 63 |
negative | 28 | |
unknown | 9 | |
Her-2/neu | positive | 18 |
negative | 57 | |
unknown | 25 | |
Visceral metastasis present | 57 | |
Bone metastasis only | 43 | |
Prior chemotherapy | None | 18 |
One line | 46 | |
≥ 2 lines | 23 | |
unknown | 13 |